Atlas Trials

The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI

Clinical trial NCT03758248 · UNKNOWN

Trial details

NCT number
NCT03758248
Sponsor
Beijing Anzhen Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Antiplatelet TherapyCYP2C19 Polymorphism
Start date
2018-12-01
Primary completion
2021-08-31
Enrollment
12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.